Literature DB >> 27573045

Downregulated expression of miRNA-149 promotes apoptosis in side population cells sorted from the TSU prostate cancer cell line.

Yatong Chen1, Jiahui Zhao1, Yong Luo1, Yongxing Wang1, Yongguang Jiang1.   

Abstract

The objective of the present study was to identify prostate cancer stem cells and determine the effects of modulating specific miRNAs on prostate CSC proliferation and apoptosis. We applied flow cytometry sorting of side population cells to cultures of prostate cancer cell lines (TSU, DU145, PC-3 and LNCaP). The proportion of SP cells in the TSU line was 1.60±0.40% (mean ± SD), while that of the DU145, PC-3 and LNCaP lines was 0.60±0.05, 0.80±0.05 and 0.60±0.20%, respectively. Because the proportion of SP cells derived from TSU cells is greater, these cells were selected to sort side population cells and non-side population cells. The stem-like properties of SP cells had been identified by in vivo and in vitro experiments, and the related study was published. RNA was extracted from the SP cells and non-SP cells and analyzed using miRNA microarray technology. Fifty-three miRNAs with significant differences in their expression were detected in total. Furthermore, 20 of these miRNAs were validated by qPCR. We found that hsa-miR‑149 expression in SP cells and non-SP cells was significantly different; hsa-miR-149 was significantly upregulated in SP cells. By constructing a vector for lentiviral infection, we found that the downregulation of hsa-miR-149 leads to a reduction in proliferation, an increase in apoptosis, and a significant reduction in the colony formation potential, thus, inhibiting tumor growth in vivo of SP cells from the TSU cell line. The present study will provide new avenues toward understanding the function of prostate cancer stem cells (PCSCs) in tumorigenicity and metastasis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27573045     DOI: 10.3892/or.2016.5047

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  MicroRNA-149 suppresses the proliferation and increases the sensitivity of ovarian cancer cells to cisplatin by targeting X-linked inhibitor of apoptosis.

Authors:  Lin Sun; Ruixia Zhai; Li Zhang; Shuping Zhao
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

2.  MicroRNA-429 acts as a tumor suppressor in colorectal cancer by targeting high mobility group box 3.

Authors:  Xiangyang Tian; Jianlan Chang; Ningning Zhang; Shouxin Wu; Huimin Liu; Junyan Yu
Journal:  Oncol Lett       Date:  2021-02-03       Impact factor: 2.967

3.  Hsa-miR-149-5p Suppresses Prostate Carcinoma Malignancy by Suppressing RGS17.

Authors:  Jinhua Ma; Hongbing Wei; Xianlin Li; Xi Qu
Journal:  Cancer Manag Res       Date:  2021-03-25       Impact factor: 3.989

4.  Diagnostic Value of Prostate-Specific Antigen Combined with Plasma miRNA-149 Expression in Patients with Prostate Cancer Based on Experimental Data and Bioinformatics.

Authors:  Hao Wang; Ling Yang; Ying Mi; Yanan Wang; Chunmei Ma; Jing Zhao; Ping Liu; Yu Gao; Peijun Li
Journal:  Contrast Media Mol Imaging       Date:  2022-07-22       Impact factor: 3.009

5.  Differential expression of circulating serum miR-1249-3p, miR-3195, and miR-3692-3p in non-small cell lung cancer.

Authors:  Sachin Kumar; Surender K Sharawat; Ashraf Ali; Vikas Gaur; Prabhat Singh Malik; Monu Pandey; Sunil Kumar; Anant Mohan; Randeep Guleria
Journal:  Hum Cell       Date:  2020-03-25       Impact factor: 4.174

Review 6.  miR-149 in Human Cancer: A Systemic Review.

Authors:  Yunjie He; Dandan Yu; Lingping Zhu; Shanliang Zhong; Jianhua Zhao; Jinhai Tang
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

7.  Dinitrosopiperazine-decreased PKP3 through upregulating miR-149 participates in nasopharyngeal carcinoma metastasis.

Authors:  Yuejin Li; Kunyu Ju; Weiwei Wang; Zheliang Liu; Haitao Xie; Yuan Jiang; Guanmin Jiang; Jinping Lu; Zigang Dong; Faqing Tang
Journal:  Mol Carcinog       Date:  2018-09-19       Impact factor: 4.784

8.  Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma.

Authors:  Feifei Fan; Yu Ping; Li Yang; Xiaoran Duan; Nomathamsanqa Resegofetse Maimela; Bingjie Li; Xiangnan Li; Jing Chen; Kai Zhang; Liping Wang; Shasha Liu; Xuan Zhao; Hongmin Wang; Yi Zhang
Journal:  J Cell Mol Med       Date:  2020-08-29       Impact factor: 5.310

9.  MicroRNA‑149 inhibits cancer cell malignant phenotype by regulating Akt1 in C4‑2 CRPC cell line.

Authors:  Jiahui Zhao; Qiankun Li; Bingfu Feng; Dechao Wei; Yili Han; Mingchuan Li; Yongxing Wang; Yong Luo; Yongguang Jiang
Journal:  Oncol Rep       Date:  2021-10-26       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.